Wieckowska M, Cichon N, Szelenberger R, Gorniak L, Bijak M
Cancers (Basel). 2024; 16(20).
PMID: 39456567
PMC: 11506779.
DOI: 10.3390/cancers16203473.
Cui H, Du J, Xue H, Zhao Y, Li C
Front Genet. 2024; 15:1391542.
PMID: 38957811
PMC: 11217166.
DOI: 10.3389/fgene.2024.1391542.
Wang L, Du H, Sheng C, Dai H, Chen K
Lipids Health Dis. 2024; 23(1):142.
PMID: 38760801
PMC: 11100063.
DOI: 10.1186/s12944-024-02138-5.
Hisamatsu T, Kadota A, Hayakawa T, Kita Y, Harada A, Okami Y
Hypertens Res. 2023; 47(1):206-214.
PMID: 37993591
DOI: 10.1038/s41440-023-01497-3.
Ali J, Aziz M, Rashid M, Basher M, Islam M
Health Sci Rep. 2022; 5(3):e650.
PMID: 35620545
PMC: 9125877.
DOI: 10.1002/hsr2.650.
The relationship between blood pressure and risk of renal cell carcinoma.
Alcala K, Mariosa D, Smith-Byrne K, Nesheli D, Carreras-Torres R, Aicua E
Int J Epidemiol. 2022; 51(4):1317-1327.
PMID: 35312764
PMC: 9365619.
DOI: 10.1093/ije/dyac042.
The Distribution of Cardiovascular-Related Comorbidities in Different Adult-Onset Cancers and Related Risk Factors: Analysis of 10 Year Retrospective Data.
Li Q, Liu F, Tang Y, Lee S, Lang C, Bai L
Front Cardiovasc Med. 2021; 8:695454.
PMID: 34595215
PMC: 8476781.
DOI: 10.3389/fcvm.2021.695454.
Asymmetric desorption of lipid oxidation products induces membrane bending.
Jin R, Baumgart T
Soft Matter. 2021; 17(32):7506-7515.
PMID: 34338699
PMC: 8425771.
DOI: 10.1039/d1sm00652e.
Bioinformatic gene analysis for possible biomarkers and therapeutic targets of hypertension-related renal cell carcinoma.
Huang W, Wu K, Wu R, Chen Z, Zhai W, Zheng J
Transl Androl Urol. 2021; 9(6):2675-2687.
PMID: 33457239
PMC: 7807377.
DOI: 10.21037/tau-20-817.
Squalene deters drivers of RCC disease progression beyond VHL status.
Rajamani K, Thirugnanasambandan S, Natesan C, Subramaniam S, Thangavel B, Aravindan N
Cell Biol Toxicol. 2020; 37(4):611-631.
PMID: 33219891
DOI: 10.1007/s10565-020-09566-w.
Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?.
Battistoni A, Volpe M
Eur Cardiol. 2020; 15:e21.
PMID: 32419852
PMC: 7215559.
DOI: 10.15420/ecr.2019.21.
Association of Hypertension and Blood Pressure With Kidney Cancer Risk: A Nationwide Population-Based Cohort Study.
Kim C, Han K, Choi H, Bae E, Ma S, Kim S
Hypertension. 2020; 75(6):1439-1446.
PMID: 32336229
PMC: 7682799.
DOI: 10.1161/HYPERTENSIONAHA.120.14820.
Influence of Hypertension on the Survival of Non-Small Cell Lung Cancer Patients with Type 2 Diabetes Mellitus.
Zeng X, Zeng D, Cheng J, Xu C, Sun C, Long H
Med Sci Monit. 2020; 26:e921676.
PMID: 32305990
PMC: 7191951.
DOI: 10.12659/MSM.921676.
Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma.
Yang F, Zhou Q, Xing N
J Cancer Res Clin Oncol. 2019; 146(1):261-272.
PMID: 31677114
DOI: 10.1007/s00432-019-03058-z.
Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study.
Karabay E, Karsiyakali N, Duvar S, Tosun C, Aslan A, Yucebas O
BMC Urol. 2019; 19(1):85.
PMID: 31519200
PMC: 6743186.
DOI: 10.1186/s12894-019-0514-0.
Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.
Christakoudi S, Kakourou A, Markozannes G, Tzoulaki I, Weiderpass E, Brennan P
Int J Cancer. 2019; 146(10):2680-2693.
PMID: 31319002
PMC: 7115826.
DOI: 10.1002/ijc.32576.
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies.
Seretis A, Cividini S, Markozannes G, Tseretopoulou X, Lopez D, Ntzani E
Sci Rep. 2019; 9(1):8565.
PMID: 31189941
PMC: 6561976.
DOI: 10.1038/s41598-019-45014-4.
Hypertensive nephropathy and cancer: Is it the hypertension, the nephropathy, or both?.
Karam S
J Clin Hypertens (Greenwich). 2019; 21(6):792-793.
PMID: 31127696
PMC: 8030280.
DOI: 10.1111/jch.13562.
Antioxidants as Renoprotective Agents for Ischemia during Partial Nephrectomy.
Buys-Goncalves G, Abreu L, Gregorio B, Sampaio F, Pereira-Sampaio M, De Souza D
Biomed Res Int. 2019; 2019:8575398.
PMID: 30882000
PMC: 6383545.
DOI: 10.1155/2019/8575398.
Epidemiology of Renal Cell Carcinoma.
Capitanio U, Bensalah K, Bex A, Boorjian S, Bray F, Coleman J
Eur Urol. 2018; 75(1):74-84.
PMID: 30243799
PMC: 8397918.
DOI: 10.1016/j.eururo.2018.08.036.